These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6210590)

  • 1. The low dose streptozotocin murine model of type 1 (insulin-dependent) diabetes mellitus: studies in vivo and in vitro of the modulating effect of sex hormones.
    Kromann H; Christy M; Lernmark A; Nedergaard M; Nerup J
    Diabetologia; 1982 Mar; 22(3):194-8. PubMed ID: 6210590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on sex dependency of B-cell susceptibility to streptozotocin in a rat model of type II diabetes mellitus.
    Ostenson CG; Grill V; Roos M
    Exp Clin Endocrinol; 1989 May; 93(2-3):241-7. PubMed ID: 2528471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic expression of interleukin 10 in the pancreas renders resistant mice susceptible to low dose streptozotocin-induced diabetes.
    Mueller R; Lee MS; Sawyer SP; Sarvetnick N
    J Autoimmun; 1996 Apr; 9(2):151-8. PubMed ID: 8738958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple low-dose streptozotocin-induced diabetes in the mouse: further evidence for involvement of an anti-B cell cytotoxic cellular auto-immune response.
    McEvoy RC; Thomas NM; Hellerström C; Ginsberg-Fellner F; Moran TM
    Diabetologia; 1987 Apr; 30(4):232-8. PubMed ID: 2954873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of H-2 genetic influence on streptozotocin-induced diabetes in mice.
    Kromann H; Christy M; Egeberg J; Lernmark A; Nerup J
    Diabetologia; 1982 Aug; 23(2):114-8. PubMed ID: 6215276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet blood flow in multiple low dose streptozotocin-treated wild-type and inducible nitric oxide synthase-deficient mice.
    Carlsson PO; Flodström M; Sandler S
    Endocrinology; 2000 Aug; 141(8):2752-7. PubMed ID: 10919259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin.
    Bonnevie-Nielsen V; Steffes MW; Lernmark A
    Diabetes; 1981 May; 30(5):424-9. PubMed ID: 6453032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
    Herold KC; Baumann E; Vezys V; Buckingham F
    J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-diabetogenic effect of essential fatty acid deficiency in multiple low-dose streptozotocin-treated mice persists if essential fatty acid repletion occurs outside of a brief window of susceptibility.
    Wright JR; Haliburton B; Russell H; Henry M; Fraser R; Cook HW
    Diabetologia; 1991 Oct; 34(10):709-14. PubMed ID: 1835705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.
    McEvoy RC; Andersson J; Sandler S; Hellerström C
    J Clin Invest; 1984 Sep; 74(3):715-22. PubMed ID: 6088584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of insulin-dependent diabetes by streptozotocin. Inhibition by estrogens and potentiation by androgens.
    Paik SG; Michelis MA; Kim YT; Shin S
    Diabetes; 1982 Aug; 31(8 Pt 1):724-9. PubMed ID: 6219020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of islet isografts despite cytotoxicity against pancreatic islets measured in vitro.
    Ziegler B; Köhler E; Klöting I; Besch W; Ziegler M
    Exp Clin Endocrinol; 1990 Feb; 95(1):31-8. PubMed ID: 2139850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma glucose and pancreatic insulin content in the early phase of streptozotocin-induced diabetes (preliminary results).
    Hahn HJ; Hagen R; Knobloch C; Besch W
    Acta Biol Med Ger; 1981; 40(1):83-5. PubMed ID: 6455026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotoxicological effects of streptozotocin and alloxan: in vitro and in vivo studies.
    Diab RA; Fares M; Abedi-Valugerdi M; Kumagai-Braesch M; Holgersson J; Hassan M
    Immunol Lett; 2015 Feb; 163(2):193-8. PubMed ID: 25573197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very-low-dose streptozotocin induces diabetes in insulin promoter-mB7-1 transgenic mice.
    Harlan DM; Barnett MA; Abe R; Pechhold K; Patterson NB; Gray GS; June CH
    Diabetes; 1995 Jul; 44(7):816-23. PubMed ID: 7540575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon secretion by dispersed alpha cell enriched islets from streptozotocin treated hamsters in perifusion.
    Dunbar JC; Brown A
    Horm Metab Res; 1984 May; 16(5):221-5. PubMed ID: 6234215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell-adherent splenocytes precede the onset of diabetes in low-dose streptozotocin-treated mice.
    Feve B; Segain JP; Charbonnel B; Sai P
    Diabetologia; 1990 Jan; 33(1):9-14. PubMed ID: 2137423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The orphan nuclear receptor small heterodimer partner negatively regulates pancreatic beta cell survival and hyperglycemia in multiple low-dose streptozotocin-induced type 1 diabetic mice.
    Noh JR; Hwang JH; Kim YH; Kim KS; Gang GT; Kim SW; Kim DK; Shong M; Lee IK; Choi HS; Lee CH
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1538-45. PubMed ID: 23680671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse.
    Campbell IL; Oxbrow L; Koulmanda M; Harrison LC
    J Immunol; 1988 Feb; 140(4):1111-6. PubMed ID: 2963859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.